Quoin Pharmaceuticals, Ltd. (QNRX)
USD 0.56
(-6.65%)
USD 0.56
(-6.65%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -7.84 Million | -8.48 Million | -5.72 Million | -1.33 Million | -1.29 Million | -6.57 Million |
| Net Income | -8.66 Million | -9.38 Million | -21.46 Million | -2.09 Million | -1.56 Million | -5.59 Million |
| Depreciation & Amortization | 103.43 Thousand | 104.04 Thousand | 104.04 Thousand | 104.04 Thousand | 20.71 Thousand | 125.72 Thousand |
| Deferred income taxes | -53.92 Million | - | - | - | - | - |
| Stock-based compensation | 1.09 Million | 764 Thousand | - | - | - | - |
| Change in working capital | 95.2 Thousand | -94.35 Thousand | 1.32 Million | 274.35 Thousand | 240.83 Thousand | 233.91 Thousand |
| Other non-cash items | 53.45 Million | 127.06 Thousand | 14.3 Million | 378.33 Thousand | -512.76 Thousand | -1.09 Million |
| Investing Cash Flow | 2.18 Million | -10.14 Million | -625 Thousand | -125 Thousand | -108 Thousand | 3.81 Million |
| Investments in PPE | 3.77 | -250 Thousand | -625 Thousand | -125 Thousand | -123 Thousand | -182.46 Thousand |
| Acquisitions | - | - | - | - | 1683.97 | - |
| Investment purchases | -18.04 Million | -9.89 Million | - | - | -4209.93 | -6119.16 |
| Sales/Maturities of investments | 20.22 Million | 14.87 Billion | - | - | 2525.96 | 4 Million |
| Other Investing Activities | 2188.32 | -14.87 Billion | -625.00 | -125.00 | 15 Thousand | 3.83 Million |
| Financing Cash Flow | 5.21 Million | 14 Million | 13.5 Million | 1.78 Million | 1.29 Million | 3.54 Million |
| Debt repayment | -600 Thousand | -311.67 Thousand | -3.47 Million | -916.36 Thousand | -146.5 Thousand | - |
| Dividends payments | - | -65.26 Million | - | - | - | - |
| Common Stock Repurchased | - | -14.81 Million | - | - | - | - |
| Common Stock Issuance | 5.83 Million | 14.81 Million | 10.1 Million | -142.32 Thousand | 6.28 Million | 3.54 Million |
| Other Financing Activities | 5.21 Million | 14.31 Million | 6.87 Million | 1.78 Million | -4.83 Million | - |
| Accounts receivables | - | - | - | 60.19 Thousand | 108.05 Thousand | 11.96 Thousand |
| Accounts payables | 53.78 Thousand | -217.8 Thousand | 1.34 Million | 227.31 Thousand | 240.83 Thousand | - |
| Inventory | - | - | - | -60.19 Thousand | 358.68 Thousand | - |
| Other working capital | 41.41 Thousand | 123.45 Thousand | -18.67 Thousand | 47.04 Thousand | -466.74 Thousand | 221.95 Thousand |
| Cash at beginning of period | 2.86 Million | 7.48 Million | 323.83 Thousand | 5.24 Million | 40.00 | 3.95 Million |
| Cash at end of period | 2.4 Million | 2.86 Million | 7.48 Million | 323.83 Thousand | 5.24 Million | 4.76 Million |
| Capital Expenditure | 3.77 | -250 Thousand | -625 Thousand | -125 Thousand | -123 Thousand | -182.46 Thousand |
| Effect of forex changes on cash | -458.97 Million | - | - | -5.24 Million | 108 Thousand | - |
| Net cash flow / Change in cash | -459.45 Thousand | -4.62 Million | 7.15 Million | -4.91 Million | 5.24 Million | 809.82 Thousand |
| Free Cash Flow | -7.84 Million | -8.73 Million | -6.34 Million | -1.46 Million | -1.42 Million | -6.75 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.96 Million | -2.35 Million | -8.66 Million | -2.07 Million | -1.92 Million | -2.1 Million |
| Depreciation & Amortization | 24.9 Thousand | 25.27 Thousand | 103.43 Thousand | 25.95 Thousand | 26.01 Thousand | 26.01 Thousand |
| Deferred income taxes | - | - | -53.92 Million | -1.33 Million | - | - |
| Stock-based compensation | 313.12 Thousand | 306.31 Thousand | 1.09 Million | 300.19 Thousand | 268.5 Thousand | 264.37 Thousand |
| Change in working capital | -353.25 Thousand | 665.91 Thousand | 95.2 Thousand | -1.37 Million | 449.35 Thousand | 340.96 Thousand |
| Other non-cash items | 617.04 Thousand | -387.42 Thousand | 53.45 Million | 1.2 Million | -138.71 Thousand | -97.13 Thousand |
| Investing Cash Flow | 3.19 Million | -4.51 Million | 2.18 Million | 2.63 Million | 821.00 | 3.03 Million |
| Investments in PPE | 0.27 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | 68.38 Thousand | -9.75 Million | -18.04 Million | -177.67 Thousand | -4.59 Million | 9804.96 |
| Sales/Maturities of investments | 3.13 Million | 5.24 Million | 20.22 Million | 2.81 Million | 4.6 Million | 3.03 Million |
| Other Investing Activities | 3.15 Million | -4.46 Million | 2188.32 | 2644.00 | 0.82 | -9804.96 |
| Financing Cash Flow | -174.61 Thousand | 5.39 Million | 5.21 Million | -182.58 Thousand | -275 Thousand | -75 Thousand |
| Debt repayment | -150 Thousand | -150 Thousand | -600 Thousand | -150 Thousand | -275 Thousand | -75 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -25.07 Thousand | 5.54 Million | 5.83 Million | 57.44 Thousand | -13.51 Thousand | -4250.96 |
| Other Financing Activities | -149.53 Thousand | -151.66 Thousand | 5.21 Million | -182.58 Thousand | -275 Thousand | -75 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -277.04 Thousand | 649.6 Thousand | 53.78 Thousand | -986.03 Thousand | 286.21 Thousand | 174.08 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -76.2 Thousand | 16.3 Thousand | 41.41 Thousand | -393.25 Thousand | 163.14 Thousand | 166.88 Thousand |
| Cash at beginning of period | 1.83 Million | 2.4 Million | 2.86 Million | 3.16 Million | 4.75 Million | 3.37 Million |
| Cash at end of period | 2.84 Million | 1.83 Million | 2.4 Million | 2.4 Million | 3.16 Million | 4.75 Million |
| Capital Expenditure | 0.27 | - | - | - | - | - |
| Effect of forex changes on cash | - | - | -458.97 Million | -4875.00 | - | - |
| Net cash flow / Change in cash | 1.01 Million | -567.67 Thousand | -459.45 Thousand | -762.16 Thousand | -1.59 Million | 1.38 Million |
| Free Cash Flow | -2 Million | -1.45 Million | -7.84 Million | -3.26 Million | -1.32 Million | -1.57 Million |
BRLXF
2191
015860
HROWL
IMC
FLIDY